Colchicine Protective Effect in Patients Undergoing Percutaneous Coronary Intervention (COLCHICINE-PROTECT)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.

Also called NCT05739929

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05739929
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05739929. Randomized; quadruple masking; primary purpose treatment. Start 2023-03-01 (actual); primary completion 2024-08-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colchicine Protective Effect in Patients Undergoing Percutaneous Coronary Intervention (COLCHICINE-PROTECT)
Intervention (Drug)
Colchicine 0.5 MG Oral Tablet
Intervention (Drug)
Placebo
Lead sponsor
Helwan University (class: other)

Record details

Record id
cardio:ct-nct05739929
Content hash
c0203912cbc4ff05c75bdda1fde560d176974b726efb6e7f6debd446e1d072f5